Fiserv Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Fiserv Inc. Common Stock trades at $46.27 (market cap $24.81B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Fiserv Inc. Common Stock is far larger — about 13.8× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Fiserv Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fiserv Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| FISV | VIR | |
|---|---|---|
Market Cap | $24.81B | $1.80B |
Volume | 4,091,234 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $126.54 | $11.78 |
52-Week Low | $44.36 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $52.60B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Fiserv, Inc. is a global provider of payments and financial services technology, offering merchant acquiring, digital commerce, and financial solutions through its Merchant Solutions and Financial Solutions segments.
Read more on FISV →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →